Adams Respiratory Therapeutics, Inc. 4
4 · Adams Respiratory Therapeutics, Inc. · Filed Apr 25, 2007
Insider Transaction Report
Form 4
Casale Robert Daniel
EVP, Chief Mktg & Devel. Off.
Transactions
- Sale
Common Stock
2007-04-25$37.80/sh−300$11,340→ 0 total - Sale
Common Stock
2007-04-25$37.54/sh−800$30,032→ 1,300 total - Exercise/Conversion
Common Stock
2007-04-25$1.42/sh+3,000$4,260→ 3,000 total - Sale
Common Stock
2007-04-25$37.45/sh−100$3,745→ 2,900 total - Sale
Common Stock
2007-04-25$37.46/sh−600$22,476→ 2,300 total - Exercise/Conversion
Stock Option (Right to Buy)
2007-04-25−3,000→ 57,960 totalExercise: $1.42Exp: 2014-02-27→ Common Stock (3,000 underlying)
Footnotes (2)
- [F1]The exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 13, 2007.
- [F2]The option vests in prorata monthly installments over five years, beginning on April 1, 2004.